SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017141
Filing Date
2022-11-09
Accepted
2022-11-09 16:07:17
Documents
54
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20220930x10q.htm   iXBRL 10-Q 1248560
2 EX-31.1 armp-20220930xex31d1.htm EX-31.1 15466
3 EX-31.2 armp-20220930xex31d2.htm EX-31.2 15284
4 EX-32.1 armp-20220930xex32d1.htm EX-32.1 8024
5 EX-32.2 armp-20220930xex32d2.htm EX-32.2 8256
6 GRAPHIC armp-20220930x10q001.jpg GRAPHIC 45064
  Complete submission text file 0001558370-22-017141.txt   4678742

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20220930.xsd EX-101.SCH 33638
8 EX-101.CAL armp-20220930_cal.xml EX-101.CAL 33559
9 EX-101.DEF armp-20220930_def.xml EX-101.DEF 145272
10 EX-101.LAB armp-20220930_lab.xml EX-101.LAB 268704
11 EX-101.PRE armp-20220930_pre.xml EX-101.PRE 239826
48 EXTRACTED XBRL INSTANCE DOCUMENT armp-20220930x10q_htm.xml XML 622516
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 221372567
SIC: 2836 Biological Products, (No Diagnostic Substances)